Trident Texofab Ltd Falls to 52-Week Low of Rs.58.1 Amid Continued Downtrend

Stock Price Movement and Market Context

On 9 Mar 2026, Trident Texofab Ltd opened at Rs.58.1, immediately reflecting a gap down of -4.99% from the previous close. The stock traded steadily at this level throughout the day, touching an intraday low of Rs.58.1, which represents its lowest price point in the past 52 weeks. This decline contrasts with the broader Garments & Apparels sector, which fell by -2.74% on the same day, indicating that Trident Texofab’s performance was notably weaker than its peers.

The stock has been on a continuous downward trend for 21 consecutive trading sessions, resulting in a cumulative loss of -65.8% over this period. This stark decline has contributed to a one-year total return of -67.09%, significantly underperforming the Sensex, which has gained 3.82% over the same timeframe. The Sensex itself opened with a gap down of -2.36% on the day, trading at 77,166.04 points, continuing its three-week losing streak with a cumulative fall of -6.82%.

Technical Indicators and Moving Averages

Trident Texofab’s share price is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning underscores the sustained bearish momentum in the stock. The absence of any intraday price range movement beyond Rs.58.1 on the day further highlights the lack of buying interest at this level.

Fundamental Performance and Financial Metrics

Trident Texofab Ltd operates within the Garments & Apparels industry and currently holds a Market Capitalisation Grade of 4. Despite its sector presence, the company’s fundamental strength has been assessed as weak, reflected in its low Return on Capital Employed (ROCE) averaging 6.88%. This figure indicates limited efficiency in generating returns from its capital base over the long term.

Debt servicing capacity remains a concern, with a high Debt to EBITDA ratio of 6.83 times, signalling elevated leverage and potential strain on cash flows. The company’s quarterly net sales have also been subdued, with the latest reported figure at Rs.25.74 crores, marking the lowest quarterly sales level recorded recently.

Over the past year, the stock’s performance has been below par not only in the short term but also over longer horizons. It has underperformed the BSE500 index across the last three years, one year, and three months, highlighting persistent challenges in maintaining competitive growth and profitability.

Valuation and Profitability Considerations

Despite the weak price performance, Trident Texofab exhibits some valuation attributes that may be considered attractive relative to its peers. The company’s ROCE of 7.4% and an Enterprise Value to Capital Employed ratio of 1.4 suggest that the stock is trading at a discount compared to historical valuations within the sector. Furthermore, the company’s profits have increased by 122.5% over the past year, a notable improvement amid the declining share price.

The Price/Earnings to Growth (PEG) ratio stands at 0.6, indicating that the stock’s valuation is relatively low compared to its earnings growth rate. However, these factors have not translated into positive market sentiment or price recovery to date.

Shareholding Pattern and Market Sentiment

The majority of Trident Texofab’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics. The company’s Mojo Score currently stands at 23.0, with a Mojo Grade of Strong Sell, an upgrade from the previous Sell rating issued on 3 Feb 2026. This grading reflects the comprehensive assessment of the company’s financial health, market performance, and risk factors.

Sector and Broader Market Environment

The Garments & Apparels sector has experienced a decline of -2.74% on the day Trident Texofab hit its 52-week low, indicating sector-wide pressures. The broader market, represented by the Sensex, has also been under pressure, trading below its 50-day moving average despite the 50DMA remaining above the 200DMA. The India VIX index reached a new 52-week high on the same day, signalling elevated market volatility and uncertainty.

Trident Texofab’s 52-week high was Rs.379, underscoring the magnitude of the stock’s decline over the past year. The current price level of Rs.58.1 represents a significant contraction in market valuation, reflecting the cumulative impact of financial performance, leverage concerns, and market sentiment.

Summary of Key Metrics

To summarise, Trident Texofab Ltd’s stock has experienced a sustained decline culminating in a 52-week low of Rs.58.1. The stock’s performance has lagged the sector and broader market indices, with a one-year return of -67.09%. Financial metrics reveal weak long-term capital returns, high leverage, and subdued sales, although profit growth and valuation ratios present a more nuanced picture. The company’s Mojo Grade of Strong Sell reflects the overall assessment of risk and performance challenges.

These factors collectively illustrate the current state of the stock and its position within the Garments & Apparels industry and the wider market environment as of early March 2026.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →